Skip to main content
. 2012 Aug 15;7(8):e42065. doi: 10.1371/journal.pone.0042065

Figure 2. Principal component analysis for VAP− and VAP+ patients.

Figure 2

(a) Sample clustering of patients that went on to develop ventilator-associated pneumonia (blue) and those that did not (red) using principal component analysis of 810 differentially expressed genes. (b) Sample clustering of patients that went on to develop ventilator-associated pneumonia (blue) and those that did not (red) using principal component analysis of 5 genes that were common to all sets in the cross validation tests.